Evidence map›Paper›PMID 37733089›Full record

ArticleWorld journal of urology2023

Opioid-free percutaneous nephrolithotomy: an initial experience.

Raymond Khargi, Alan J Yaghoubian, Ryan M Blake, Anna Ricapito, Christopher Connors, Blair Gallante, Johnathan A Khusid, William Atallah, Mantu Gupta

Abstract read
PubMed Publisher
In one paragraph

Article in World journal of urology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Raymond KhargiDepartment of Urology, Icahn School of Medicine, New York, NY, USA. raymond.khargi2@mountsinai.org.ORCID http://orcid.org/0000-0001-5005-8620
Alan J YaghoubianDepartment of Urology, Icahn School of Medicine, New York, NY, USA.
Ryan M BlakeDepartment of Urology, Icahn School of Medicine, New York, NY, USA.
Anna RicapitoDepartment of Urology and Kidney Transplant, University of Foggia, Foggia, Italy.
Christopher ConnorsDepartment of Urology, Icahn School of Medicine, New York, NY, USA.
Blair GallanteDepartment of Urology, Icahn School of Medicine, New York, NY, USA.
Johnathan A KhusidDepartment of Urology, Icahn School of Medicine, New York, NY, USA.
William AtallahDepartment of Urology, Icahn School of Medicine, New York, NY, USA.
Mantu GuptaDepartment of Urology, Icahn School of Medicine, New York, NY, USA.
Icahn School of Medicine at Mount Sinai · USUniversity of Foggia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe opioid epidemic in the United States is an ongoing public health crisis that is in part fueled by excessive prescribing by physicians. Percutaneous nephrolithotomy (PCNL) is a procedure that conventionally involves opioid prescriptions for adequate post-operative pain control. We aimed to evaluate the feasibility of a non-opioid pain regimen by evaluating post-operative outcomes in PCNL patients discharged without opioids. MATERIALS AND

methodsAs a quality improvement measure to reduce opioid consumption our department began routinely prescribing oral ketorolac instead of oxycodone-acetaminophen for pain control after PCNL. We retrospectively compared patients undergoing PCNL who had received ketorolac prescriptions (NSAID) to those who received oxycodone-acetaminophen prescriptions (NARC). Demographic, operative, and post-operative factors were obtained and compared in both groups. Peri-operative factors and demographics were compared using either Chi-squared tests, Mann-Whitney U tests. Surgical outcomes were compared between the two groups using Chi-squared tests and Fisher's exact tests. Multivariate logistic regression analysis was performed to determine whether ketorolac use was an independent predictor of post-surgical pain-related encounters. Primary outcome was unplanned pain-related healthcare encounters inclusive of office phone calls, unscheduled office visits, and emergency department (ED) visits. Secondary outcome measures were non-pain-related healthcare encounters, hospital readmissions, pain-related rescue medications prescribed, and post-op complications.

resultsThere were similar demographics and peri-operative characteristics amongst patients in both cohorts. There was no significant difference identified between NSAID and NARC regarding unplanned pain-related encounters (8/70, 11.4% vs. 10/70, 14.3%, p = 0.614). However, NARC experienced more unplanned phone calls (42, 60% vs. 24, 34.3%, p = 0.004). Multivariate analysis revealed only prior stone surgery was predictive of pain-related encounters after PCNL (p = 0.035).

conclusionOur results show that there were no significant differences in pain-related encounters between those who received ketorolac and oxycodone-acetaminophen following PCNL. A non-opioid pathway may mitigate the potential risk associated with opioid prescription without compromising analgesia. Prospective comparative studies are warranted to confirm feasibility.

Indexed as

Analgesics, OpioidNephrolithotomy, PercutaneousAnti-Inflammatory Agents, Non-SteroidalHumansKetorolacPostoperative PainProspective StudiesRetrospective StudiesAnalgesics, OpioidAnti-Inflammatory Agents, Non-SteroidalKetorolacKidney stone diseaseNSAIDsOpioidsPain controlPCNL

Identifiers

PMID37733089
OpenAlexW4386910540

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.